VANGUARD GROUP INC - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is OREXQ and the CUSIP is 686164302. A total of 53 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.52 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$429,000
-25.0%
332,895
+23.5%
0.00%
Q3 2017$572,000
-24.3%
269,607
+3.4%
0.00%
Q2 2017$756,000
-60.9%
260,814
-53.6%
0.00%
Q1 2017$1,934,000
+271.9%
562,331
+88.2%
0.00%
Q4 2016$520,000
-61.8%
298,857
-27.2%
0.00%
Q3 2016$1,363,000410,3130.00%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
BVF INC/IL 734,976$2,440,0000.46%
Baupost Group 2,226,839$7,393,0000.10%
Rhenman & Partners Asset Management AB 120,000$398,400,0000.06%
NEA Management Company, LLC 370,900$1,231,0000.06%
SAMLYN CAPITAL, LLC 616,040$2,046,0000.05%
Rock Springs Capital Management LP 165,300$549,0000.03%
Palo Alto Investors LP 167,302$555,0000.03%
Telemetry Investments, L.L.C. 10,250$34,0000.02%
TWO SIGMA SECURITIES, LLC 10,478$35,0000.01%
PDT Partners, LLC 29,800$99,0000.01%
View complete list of OREXIGEN THERAPEUTICS INC shareholders